Mitsubishi UFJ Asset Management Co. Ltd. reduced its stake in BioNTech SE (NASDAQ:BNTX – Free Report) by 20.0% in the 4th ...

Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...

Download our report to dive into some of the recent advances in vaccine technology, including mRNA vaccines, cancer vaccines, ...

The FDA has delayed granting full approval of Novavax's COVID-19 vaccine despite it being on track to be cleared until ...

Idaho’s Senate Bill 1211 would let ivermectin be sold over the counter, without a prescription or consultation with a health care professional.

Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on Novartis AG (NOVN – Research Report) today and set a price target of ...

Pembrolizumab plus concurrent chemoradiotherapy shows ongoing antitumor activity after about 5 years of follow-up in patients ...

The group had a bad week after turmoil at the FDA, continuing a long period of underperformance following the pandemic.

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Sell rating on Roche Holding AG (RHHVF – Research Report), with ...

The US drug regulator has missed a deadline for granting full approval to Novavax’s Covid-19 vaccine, the company said Wednesday, amid major shakeups at health agencies under President Donald Trump.

The North West has seen record levels of laboratory leasing, according to real estate analytics company CoStar. The leasing ...

The US Food and Drug Administration was supposed to make a final decision about whether or not to approve Novavax's (NVAX) COVID-19 vaccine this week, but that deadline has passed with no clarity on ...